Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:316-319
Published online before print January 12, 2004, doi: 10.1161/01.CIR.0000114520.38748.AA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/3/316    most recent
01.CIR.0000114520.38748.AAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsue, P. Y.
Right arrow Articles by Waters, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsue, P. Y.
Right arrow Articles by Waters, D. D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Restenosis
Right arrow Acute coronary syndromes

(Circulation. 2004;109:316-319.)
© 2004 American Heart Association, Inc.


Brief Rapid Communications

Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection

Priscilla Y. Hsue, MD; Kamini Giri, MD; Sara Erickson, MD; John S. MacGregor, MD; Naji Younes, PhD; Amandeep Shergill, MD; David D. Waters, MD

From the Division of Cardiology, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco.

Correspondence to David Waters, MD, Room 5G1, Division of Cardiology, San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA 94110. E-mail dwaters{at}medsfgh.ucsf.edu

Received October 31, 2003; revision received December 3, 2003; accepted December 4, 2003.

Background— Patients with HIV infection exhibit increased rates of coronary events; however, the clinical features of acute coronary syndromes (ACS) in HIV-infected patients have not been well defined.

Methods and Results— Between 1993 and 2003, 68 HIV-infected patients were hospitalized with ACS. We compared the clinical features and outcome of these patients with those of 68 randomly selected control patients with ACS without HIV. HIV patients were on average more than a decade younger than controls and more likely to be male and current smokers and to have low HDL cholesterol. They were less likely than controls to have diabetes or hyperlipidemia, and their TIMI (Thrombolysis In Myocardial Infarction) risk scores on admission were significantly lower. At coronary angiography, the number of vessels with >50% stenosis was 1.3±1.0 in HIV patients and 1.9±1.2 in controls (P=0.007). Restenosis developed in 15 of 29 HIV patients who underwent percutaneous coronary intervention compared with 3 of 21 controls (52% versus 14%, P=0.006).

Conclusions— HIV patients with ACS are younger and more likely to be males and current smokers and to have low HDL cholesterol levels compared with other ACS patients. Their TIMI risk scores are lower, and they are more likely to have single-vessel disease; however, their restenosis rates after percutaneous coronary intervention are unexpectedly high.


Key Words: risk factors • restenosis • coronary disease • angina • infection




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. A. Eugenin, S. Morgello, M. E. Klotman, A. Mosoian, P. A. Lento, J. W. Berman, and A. D. Schecter
Human Immunodeficiency Virus (HIV) Infects Human Arterial Smooth Muscle Cells in Vivo and in Vitro: Implications for the Pathogenesis of HIV-Mediated Vascular Disease
Am. J. Pathol., April 1, 2008; 172(4): 1100 - 1111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. F. Wu, Z. Ma, D. P. Myers, and L. S. Terada
HIV-1 Tat Activates Dual Nox Pathways Leading to Independent Activation of ERK and JNK MAP Kinases
J. Biol. Chem., December 28, 2007; 282(52): 37412 - 37419.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. Huang, A. Quartin, D. Jones, and D. V. Havlir
Intensive care of patients with HIV infection.
N. Engl. J. Med., July 13, 2006; 355(2): 173 - 181.
[Full Text] [PDF]


Home page
HeartHome page
F Boccara, E Teiger, A Cohen, S Ederhy, S Janower, G Odi, E Di Angelantonio, G Barbarini, and G Barbaro
Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis.
Heart, April 1, 2006; 92(4): 543 - 544.
[Full Text] [PDF]


Home page
CirculationHome page
P. Y. Hsue and D. D. Waters
What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection
Circulation, December 20, 2005; 112(25): 3947 - 3957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. S. Baliga, A. A. Chaves, L. Jing, L. W. Ayers, and J. A. Bauer
AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1373 - H1380.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Stenvinkel, O. Heimburger, and B. Lindholm
Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease
Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2181 - 2183.
[Full Text] [PDF]